Month: July 2022

Build Your Brand with Canva for Nonprofits Guide

Build Your Brand with Canva for Nonprofits Guide Build Your Brand with Canva for Nonprofits Sometimes it can be challenging to keep your organization’s brand cohesive and consistent. With so many documents, slide decks, flyers, and social media posts to produce (often with multiple staff members producing them) it can be overwhelming to ensure that …

Build Your Brand with Canva for Nonprofits Guide Read More »

Audit Committee v. Finance Committee: Do you need both?

The Difference Between a Nonprofit Audit Committee and a Finance Committee and Why Your Nonprofit Needs Both For nonprofits, deciding on a board committee structure can be a challenge. Often, the decision is solely based on the number of board members and their talents and expertise. However, proper financial oversight is essential to a nonprofit’s …

Audit Committee v. Finance Committee: Do you need both? Read More »

Nonprofit Audit Committee v. Finance Committee: Do you need both?

The Difference between an Audit and Finance Committee, and Why You Need Both For nonprofits, deciding on a board committee structure can be a challenge. Often, the decision is solely based on the number of board members and their talents and expertise. However, proper financial oversight is essential to a nonprofit’s success. It ensures that …

Nonprofit Audit Committee v. Finance Committee: Do you need both? Read More »

WHO applauds agreement to scale-up generic manufacturing for access to long-acting injectable antiretrovirals

WHO welcomes the announcement of a new voluntary licensing agreement for patents relating to long acting-cabotegravir (CAB-LA) between ViiV Healthcare and the Medicine Patent Pool. This agreement, will give selected generic manufacturers the opportunity to develop, manufacture and supply generic versions of CAB-LA, in 90 low- and middle-income countries, subject to required regulatory approvals. This is …

WHO applauds agreement to scale-up generic manufacturing for access to long-acting injectable antiretrovirals Read More »

WHO recommends long-acting cabotegravir for HIV prevention

WHO today released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to consider this safe and highly effective prevention option for people at substantial risk of HIV infection. The guidelines, released ahead of the 24th International AIDS Conference (AIDS 2022), will support countries …

WHO recommends long-acting cabotegravir for HIV prevention Read More »

How To Inspire and Recruit A New Generation of Donors

How To Inspire and Recruit A New Generation of Donors Guide Recruit new donors and understand your demographics “To know even one life has breathed easier because you have lived. This is to have succeeded.” ― Ralph Waldo Emerson The key to securing more donations is understanding your donors and recruit new donors. Who are your …

How To Inspire and Recruit A New Generation of Donors Read More »

WHO calls on global community to “do one thing” to save lives on World Drowning Prevention Day

Today, the World Health Organization (WHO) issued a call for people around the world to “do one thing” to prevent drowning. As one of the leading causes of death globally for children and young people ages 1–24, and the third leading cause of injury-related deaths overall, drowning tragically claims more than 236 000 lives each …

WHO calls on global community to “do one thing” to save lives on World Drowning Prevention Day Read More »

WHO publishes new guidelines on HIV, hepatitis and STIs for key populations

Today, WHO published new Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. The guidelines are officially launched at the AIDS 2022 Conference in Montreal, Canada, in a satellite session entitled: Launching new WHO guidelines for key populations: Focus for impact.  The guidelines outline a public health response …

WHO publishes new guidelines on HIV, hepatitis and STIs for key populations Read More »

Second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox

The WHO Director-General is hereby transmitting the Report of the second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox, held on Thursday, 21 July 2022, from 12:00 to 19:00 CEST. The WHO Director-General expresses his sincere gratitude to the Chair, Members, and Advisors for their careful consideration …

Second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox Read More »